CERRONE GABRIELE M

Reported to SECin USFilings at 2 companies

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 7. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

5 of 7
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
OKYO Pharma Ltd—Open-market buy$35,00025,000 sharesAug 7, 2026OKYO Pharma Ltd$35,000Buy · Aug 7Open-market buy25,000Aug 7, 2026
OKYO Pharma Ltd—Open-market buy$32,62522,500 sharesAug 7, 2026OKYO Pharma Ltd$32,625Buy · Aug 7Open-market buy22,500Aug 7, 2026
Tiziana Life Sciences Ltd—Open-market buy$41,93342,357 sharesAug 7, 2026Tiziana Life Sciences Ltd$41,933Buy · Aug 7Open-market buy42,357Aug 7, 2026
Tiziana Life Sciences Ltd—Open-market buy$16,65015,000 sharesAug 7, 2026Tiziana Life Sciences Ltd$16,650Buy · Aug 7Open-market buy15,000Aug 7, 2026
OKYO Pharma Ltd—Award$32,62522,500 sharesJul 23, 2026OKYO Pharma Ltd$32,625Award · Jul 23Award22,500Jul 23, 2026